Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cancer Research UK

Cancer Research UK
VC INVESTOR TYPE
Active STATUS
3 PROFESSIONALS
26 INVESTMENTS
19 PORTFOLIO
7 EXITS
Description

Cancer Research UK is an investment firm based in London, United Kingdom and was founded in 2002. The firm has exclusive rights of world-class cancer research annually. It offers unique opportunities to commercial partners looking for early involvement in new discoveries and is completely focused on cancer.

Formerly Known As
Cancer Research Technology
Investor Status
Actively Seeking New Investments
Year Founded
2002
Primary Investor Type
Venture Capital
Primary Office
  • Angel Building
  • 407 Saint John Street
  • London EC1V 4AD
  • England, United Kingdom

+44 020 0000 0000

Cancer Research UK Investments (26)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Azeria Therapeutics 21-Nov-2019 Early Stage VC 000.00 Drug Discovery Startup
00000000 000000000 13-Sep-2017 00000 00000 000.00 Drug Discovery Generating Revenue
0000000000 000000 23-Aug-2017 00000 00000 000.00 Biotechnology Generating Revenue
00000000 20-Jun-2017 0000 00000 Biotechnology Generating Revenue 000000 000000
0000000 05-Oct-2016 00000 00000 000.00 Business/Productivity Software Generating Revenue
000000 19-Sep-2016 00000 00000 0000 Drug Discovery Generating Revenue 0000 000000000 00.0
0000000000 0000000 15-Sep-2016 0000 00000 00.000 Biotechnology Generating Revenue 000 00000 00.0
0000000 0000000000 02-Feb-2016 00000 00000 000.00 Drug Discovery Generating Revenue
Macrophage Pharma 29-Dec-2014 Early Stage VC Biotechnology Generating Revenue
BliNK Biomedical 11-Dec-2014 Early Stage VC 00.000 Biotechnology Generating Revenue
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cancer Research UK’s full profile, request a free trial.

Cancer Research UK Exits (6)

Company Name Exit Date Exit Type Exit Size Status Buyers
BliNK Therapeutics 17-Apr-2018 Out of Business Completed
00000000 01-Jul-2015 000000000000000000 Completed
  • 00000000
00000 000000000000 28-Jan-2015 000000000000000000 Completed
  • 0000000000
0000000 000000 15-Apr-2008 000000000000000000 00000 Completed
  • 0. 00000000-00 000
KuDOS Pharmaceuticals 31-Jan-2006 Merger/Acquisition 00000 Completed
Chroma Therapeutics Out of Business Completed
To view this investor’s complete exits history, request access »

Cancer Research UK Team (15)

Name Title Deals Funds Boards Office Contact
Info
Iain Foulkes Ph.D Executive Director, Board Member & Chief Executive Officer, Cancer Research Technology London, United Kingdom
Michelle Mitchell Chief Executive Officer London, United Kingdom
Andrea Schievella Ph.D President, US Office Cambridge, MA
Tim Hammonds Ph.D Deputy Director of Drug Discovery London, United Kingdom
Stuart Farrow Director of Biology 0 0 0 Cambridge, MA

5 Former Team Members

You’re viewing 5 of 15 team members. Get the full list »